By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Oncodesign SA 

20 rue Jean Mazen
B.P. 27627
Dijon  Cedex  21076  France
Phone: 33-3-80-78-82-60 Fax: 33-3-80-78-82-61




Company News
Oncodesign SA Presents Its Latest Scientific Developments At The AACR Annual Global Meeting On Oncology 4/3/2017 11:45:54 AM
Oncodesign SA Completes The Acquisition Of François Hyafil Research Centre And Appoints Two New Strategic Activity Directors 12/1/2016 8:21:23 AM
GlaxoSmithKline (GSK) And Oncodesign SA Announce Agreement For Oncodesign’s Acquisition Of GSK’s Research Centre In France 9/28/2016 11:02:44 AM
Oncodesign SA Announces The Launch Of Its First Clinical Study On A Radiotracer In Patients With Non-Small Cell Lung Cancer 7/13/2016 10:46:55 AM
Oncodesign SA And Ipsen (IPN.PA) Enter Into A Strategic Partnership In Oncology And Oncodesign Joins Ipsen’s Paris-Saclay Campus 5/3/2016 9:41:41 AM
Bristol-Myers Squibb (BMY), Oncodesign SA Knock Out a $83 Million+ Drug Discovery Pact 1/5/2016 6:32:01 AM
Preclinical Validation Of Oncodesign SA’s First Radiotracer Prior To Human Application 12/17/2015 8:24:31 AM
Oncodesign SA Presents Novel LRRK2 Inhibitor Jointly Discovered With Ipsen At The 2015 Neurosciences Meeting In Chicago 10/22/2015 11:17:57 AM
UCB Exercises Its Option To License A Program From Oncodesign SA Targeting Neurological Diseases 6/5/2015 9:31:36 AM
Oncodesign SA Has Entered Into A Services Agreement With Eisai Inc. (ESALF.PK) To Develop A New Personalized Medicine Program In Earlier Line Metastatic Breast Cancer Treatment 12/17/2014 11:44:28 AM